gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 14 Mar 2013.

Interleukin 27

P28, IL-27, IL-20
The protein encoded by this gene is one of the subunits of a heterodimeric cytokine complex. This protein is related to interleukin 12A (IL12A). It interacts with Epstein-Barr virus induced gene 3 (EBI3), a protein similar to interleukin 12B (IL12B), and forms a complex that has been shown to drive rapid expansion of naive but not memory CD4(+) T cells. The complex is also found to synergize strongly with interleukin 12 to trigger interferon gamma (IFNG) production of naive CD4(+) T cells. The biological effects of this cytokine are mediated by the class I cytokine receptor (WSX1/TCRR). [provided by RefSeq, Jul 2008] (from NCBI)
Papers on P28
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.
New
Imamichi et al., Frederick, United States. In J Exp Med, 11 Apr 2013
IL-27 is an anti-HIV cytokine that also modulates monocyte activation.
Interleukin-35: The Future of Hyperimmune-Related Diseases?
New
Zheng et al., Hangzhou, China. In J Interferon Cytokine Res, 08 Apr 2013
It contains Epstein-Barr virus-induced gene 3 subunit and IL-27 p35 subunit.
Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses.
New
Robinson et al., Columbia, United States. In Immunology, 06 Apr 2013
Here we show that IL-27 gene expression is elevated in cord blood-derived macrophages relative to macrophages originating from healthy adults.
IL-27 inhibits lymphatic endothelial cell proliferation by STAT1-regulated gene expression.
New
Tritsarisa et al., Copenhagen, Denmark. In Microcirculation, 02 Apr 2013
OBJECTIVE: IL-27 belongs to the IL-12 family of cytokines and is recognized for its role in Th cell differentiation and as an inhibitor of tumor-angiogenesis.
Independent and Interdependent Immunoregulatory Effects of IL-27, IFN-β, and IL-10 in the Suppression of Human Th17 Cells and Murine Experimental Autoimmune Encephalomyelitis.
New
Rostami et al., Belfast, United Kingdom. In J Immunol, 01 Apr 2013
IFN-β, IL-27, and IL-10 have been shown to exert a range of similar immunoregulatory effects in murine and human experimental systems, particularly in Th1- and Th17-mediated models of autoimmune inflammatory disease.
A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.
New
Das Gupta et al., Chicago, United States. In Br J Cancer, 28 Mar 2013
Background:This first-in-human, phase I clinical trial of p28 (NSC745104), a 28-amino-acid fragment of the cupredoxin azurin, investigated the safety, tolerability, pharmacokinetics and preliminary activity of p28 in patients with p53+ metastatic solid tumours.Methods:A total of 15 patients were administered p28 i.v. as a short infusion three times per week for 4 weeks followed by a 2-week rest under an accelerated titration 3+3 dose escalation design until either a grade 3-related adverse event occurred or the maximum tolerated dose (MTD) was reached.
Interleukin-27: balancing protective and pathological immunity.
Review
New
Impact
Kastelein et al., Philadelphia, United States. In Immunity, Jan 2013
It has been more than 15 years since the identification of individual interleukin-27 (IL-27) and IL-27 receptor components.
CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis.
New
Nixon et al., São Paulo, Brazil. In Plos One, Dec 2012
We also assessed functionality of the T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-gamma, IL-2, IL-33, TNF-alpha, IL-21, IL-22, and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin biopsies of psoriasis patients.
Respiratory syncytial virus infection and chronic respiratory morbidity - is there a functional or genetic predisposition?
Review
New
Greenough et al., London, United Kingdom. In Acta Paediatr, Nov 2012
Conclusion:  Single-nucleotide polymorphisms in genes coding for IL-8, IL-19, IL-20, IL-13 mannose-binding lectin, IFNG and a RANTES polymorphism have been associated with subsequent wheeze following RSV LRTI in term-born infants.
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.
Review
New
Impact
O'Garra et al., Dallas, United States. In Nat Immunol, Oct 2012
Interleukin 2 (IL-2), IL-10 and transforming growth factor-β (TGF-β) are well characterized, whereas IL-27, IL-35 and IL-37 represent newcomers to the spectrum of anti-inflammatory cytokines.
Treg cells acquire new directions, cytokines navigate.
New
Impact
Sakaguchi et al., Suita, Japan. In Immunity, Oct 2012
(2012) demonstrate that IFN-γ and IL-27 distinctly induces T-bet(+) Treg cells via STAT-1 transcription factor activation.
The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.
New
Impact
Hunter et al., Philadelphia, United States. In Immunity, Oct 2012
Our studies demonstrate that interleukin-27 (IL-27) also promoted expression of T-bet and CXCR3 in Treg cells.
Atopic dermatitis and cytokines: the immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part II: negative regulation and cytokine therapy in atopic dermatitis.
Review
New
Lee et al., Taejŏn, South Korea. In Recent Pat Inflamm Allergy Drug Discov, Sep 2012
Recently, the IL-27, IL-21, and IL-10 cytokines were found to be important components of the counter regulatory mechanism that terminates immune response, and protects the host from excessive immune responses.
Atopic dermatitis and cytokines: recent patents in immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part I: cytokines in atopic dermatitis.
Review
New
Rhim et al., Taejŏn, South Korea. In Recent Pat Inflamm Allergy Drug Discov, Sep 2012
Recently, the roles of new cytokines including IL-16, IL-17, IL-21, IL-22, IL-23, IL-27, IL-31, IL-33, IL-35 and thymus stromal lymphopoietin (TSLP), and Th2 polarization in the immunopathogenesis of skin inflammation and physically injured skin have been described, in addition to roles for IL-4, IL- 5, IL-9, IL-13, IFN-γ and TGF-β.
IL-12 family cytokines: immunological playmakers.
Review
New
Impact
Kuchroo et al., Memphis, United States. In Nat Immunol, Aug 2012
The interleukin 12 (IL-12) family is unique in having the only heterodimeric cytokines, including IL-12, IL-23, IL-27 and IL-35.
Memory CD4 T cells induce selective expression of IL-27 in CD8+ dendritic cells and regulate homeostatic naive T cell proliferation.
GeneRIF
Min et al., Cleveland, United States. In J Immunol, 2012
a new model for maintaining peripheral T cell homeostasis via memory CD4 T cells and CD8(+) DC-derived IL-27 in vivo.
Serum levels of interleukin (IL)-27 in patients with ischemic heart disease.
GeneRIF
Rezayati et al., Rafsanjān, Iran. In Cytokine, 2011
results showed that the higher serum levels of IL-27 were associated with ischemic heart disease
TLR2-mediated production of IL-27 and chemokines by respiratory epithelial cells promotes bleomycin-induced pulmonary fibrosis in mice.
GeneRIF
Chung et al., Seoul, South Korea. In J Immunol, 2011
TLR2 signaling promotes bleomycin-induced pulmonary fibrosis by inducing IL-27 and chemokine production by respiratory epithelial cells, thereby inhibiting IL-17 production and recruiting inflammatory cells into the lungs.
IL-12p35 subunit contributes to autoimmunity by limiting IL-27-driven regulatory responses.
GeneRIF
Mauri et al., London, United Kingdom. In J Immunol, 2011
the IL-12p35 subunit acts as negative regulator of the developing IL-27 response in this model of arthritis
Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer.
GeneRIF
Weghorst et al., Columbus, United States. In Anticancer Res, 2011
Gankyrin overexpression is a prevalent event in human oral cancer and occurs during the early stages of oral carcinogenesis, thus being a viable therapeutic or chemopreventive target in oral cancer
share on facebooktweetadd +1mail to friends